Clinical trial
Deconvolution of Colonal Hematopoiesis Associated Inflammation in Health and Disease
NCT07780552 is registered in ClinicalTrials.gov with VASCage GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Deconvolution of Colonal Hematopoiesis Associated Inflammation in Health and Disease
- Lead sponsor
- VASCage GmbH
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- March 31, 2027
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease, clonal cytopenia of undetermined significance (ccus), clonal hematopoiesis, clonal hematopoiesis of indeterminate potential, myelodysplastic syndrome, myocardial infarction (mi), st-elevation myocardial infarction (stemi)